首页> 外文期刊>Clinical and experimental pharmacology & physiology >Effect of 9-(6,7-dideoxy-beta-D-allo-hept-5-ynofuranosyl)adenine on noradrenaline release from vascular sympathetic nerves.
【24h】

Effect of 9-(6,7-dideoxy-beta-D-allo-hept-5-ynofuranosyl)adenine on noradrenaline release from vascular sympathetic nerves.

机译:9-(6,7-二脱氧-β-D-allo-hept-5-ynofuranosyl)腺嘌呤对去甲肾上腺素从血管交感神经释放的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

1. The effects of 9-(6,7-dideoxy-beta-D-allo-hept-5-ynofuranosyl)adenine (HAK2701), a selective and potent ligand for P3 receptor-like protein, on the release of endogenous noradrenaline (NA) from electrically stimulated rat mesenteric artery and rabbit ear artery were compared with those of a number of purinoceptor agonists. 2. In the rat mesenteric artery, the P1 receptor agonists 2-chloroadenosine (2CA) and 5'-N-ethylcarboxamidoadenosine (NECA) and the P2 purinoceptor agonists beta,gamma-methylene ATP (betagammamATP) and 2-methylthio ATP (2mSATP) significantly inhibited the release of NA in a xanthine-sensitive manner. HAK2701 did not significantly inhibit the release of NA, the relative order of potency being betagammamATP > NECA > 2CA > 2mSATP HAK2701. 3. In the rabbit ear artery, both P1 and P2 receptor agonists significantly facilitated the release of NA in a xanthine-sensitive manner. HAK2701 also significantly facilitated the release of NA, the relative order of potency being HAK2701 > betagammamATP > 2CA > 2mSATP > NECA. 4. These findings suggest that HAK2701 may be a potent and selective agonist for facilitatory prejunctional purinoceptors, but not for inhibitory purinoceptors, on adrenergic nerve terminals.
机译:1. 9-(6,7-二脱氧-β-D-allo-hept-5-ynofuranosyl)腺嘌呤(HAK2701),一种对P3受体样蛋白的选择性强效配体,对内源性去甲肾上腺素(将电刺激的大鼠肠系膜动脉和兔耳动脉的NA)与许多嘌呤受体激动剂的NA进行比较。 2.在大鼠肠系膜动脉中,P1受体激动剂2-氯腺苷(2CA)和5'-N-乙基羧酰胺基腺苷(NECA)和P2嘌呤受体激动剂β,γ-亚甲基ATP(betagammamATP)和2-甲硫基ATP(2mSATP)以黄嘌呤敏感的方式显着抑制NA的释放。 HAK2701没有显着抑制NA的释放,效力的相对顺序为betagammamATP> NECA> 2CA> 2mSATP HAK2701。 3.在兔耳动脉中,P1和P2受体激动剂均以黄嘌呤敏感的方式显着促进了NA的释放。 HAK2701还显着促进了NA的释放,效力的相对顺序为HAK2701> betagammamATP> 2CA> 2mSATP> NECA。 4.这些发现表明,HAK2701在肾上腺素能神经末梢可能是促进结前嘌呤受体的强效选择性激动剂,而不是抑制性嘌呤受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号